Status:
COMPLETED
To Determine the Efficacy of the TwinGuard in Oxygen Delivery During and Post Endoscopic Procedure
Lead Sponsor:
Trawax Pty Limited
Conditions:
Hypoxia
Hypercapnia
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
A comparative study which compares the end-tidal carbon dioxide and oxygen saturation levels of patients during endoscopy which have used either the new oral-nasal oxygenating device (TwinGuard), or a...
Detailed Description
Hypoxia is common during endoscopy. Following sedation induction, oxygen saturation falls moderately in most patients, whilst some drop to unacceptable levels. To monitor such changes endoscopic pract...
Eligibility Criteria
Inclusion
- Provided written fully informed consent as per protocol
- No clinical evidence of significant respiratory conditions
- Fasted for 6 hours prior to enrolment as per standard clinical practice for panendoscopy
Exclusion
- Patients suffering from cardio respiratory disease, moderate to severe asthma, lung and heart disease
- Patients who have a history of drug or alcohol abuse
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00619606
Start Date
November 1 2006
End Date
March 1 2007
Last Update
February 21 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.